Medical News

RSS

MEDNAX announces financial results for the third quarter of 2009

MEDNAX, Inc. today reported record results from operations for the three months and nine months ended September 30, 2009, that reflect contributions from acquisitions, same-unit revenue growth and operating efficiencies.

2 Nov 2009

Humana reports higher consolidated revenues for third quarter at $7.72 billion

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management’s guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.

2 Nov 2009

New Aplio MX ultrasound system from Toshiba

Hospitals use ultrasound as a first-line diagnostic exam, requiring them to have cutting-edge ultrasound technology available to quickly and efficiently perform a range of patient exams. To meet these demanding clinical needs, while also considering the financial challenges facing many hospitals today, Toshiba America Medical Systems, Inc. has introduced the AplioTM MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.

2 Nov 2009

Rap video teaches kids how to avoid getting swine flu

"Blah, blah, H1N1 blah," is what many kids hear when their parents try to teach them how to avoid getting H1N1, or the swine flu. To cut through the blahs let DocRock and his H1N1 Rap teach your kids how to avoid catching H1N1 or the regular seasonal flu.

2 Nov 2009

Nuevolution receives milestone payment from Merck

Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.

2 Nov 2009

Dietary cholesterol is not a primary factor for coronary heart disease

Contrary to the established view, current data suggest that dietary cholesterol is not a primary factor of or causes heart disease - with the possible exception of the genetic forms of familial hypercholesterolemias. For instance, recent clinical trials evaluating the effect of cholesterol-lowering drugs on the development of chronic heart failure, diabetes and stroke have yielded disappointing results.

2 Nov 2009

ACM Global Central Laboratory celebrates landmark anniversary

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe.

2 Nov 2009

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months.

2 Nov 2009

Scientists discover gene that controls the metabolism of fat

Scientists at the University of Bonn have discovered a previously unknown fruit fly gene that controls the metabolism of fat. Larvae in which this gene is defective lose their entire fat reserves.

2 Nov 2009

Aflex Hose launches the Corroline hose for transferring process fluids in pharmaceutical plants

Aflex Hose Ltd has today unveiled Corroline, a revolutionary flexible hose developed to stand up to the toughest chemical and process applications.

2 Nov 2009

Natus Medical announces a revenue of $44.3M for the third quarter of 2009

Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2009.

2 Nov 2009

AHF/Cambodia CARES to launch its AIDS testing initiative during the annual Water Festival

As part of an ambitious global effort to test several million people for HIV in observance of the Testing Millions World AIDS Day 2009 campaign, AHF/Cambodia CARES will launch its inaugural testing effort during the annual Water Festival, which marks the end of the rainy season and is the largest festival in the Cambodian calendar.

2 Nov 2009

LRI and lupus organizations congratulate HGS and GlaxoSmithKline for achieving historical landmark

The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.

2 Nov 2009

Eli Lilly selects ICON to provide clinical data management outside the US

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company (NYSE:LLY) to manage the company’s clinical data management outside the US.

2 Nov 2009

Interim data from Bristol-Myers Squibb's BARACLUDE study for chronic hepatitis B patients

Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.

2 Nov 2009

Former Connecticut Governor delivers address on health reform before Muslim Coalition of Connecticut

Lowell Weicker, Jr., former three-term U.S. Senator and Governor of Connecticut and President of the Board of the Trust for America's Health (TFAH), delivered an address on health reform before The Muslim Coalition of Connecticut. The following are excerpts from the speech:

2 Nov 2009

Women at particular risk of their primary care physicians delaying diagnosis of CKD: Study

Woman are at particular risk of their primary care physicians delaying diagnosis of chronic kidney disease (CKD), according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, California. The findings suggest that educating practitioners about CKD could increase the timely diagnosis of CKD, thereby leading to improvements in care to patients and savings in Medicare dollars.

2 Nov 2009

BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients

Bristol-Myers Squibb Company and ZymoGenetics, Inc. today presented final results from a Phase 1b clinical trial of PEG-Interferon lambda administered with ribavirin in relapsed and treatment-naïve hepatitis C virus (HCV) patients.

2 Nov 2009

Curato invests in Sectra’s digital mammography system

The Norwegian company Curato, the Nordic region’s largest provider of radiology examinations, is making a major investment in its mammography operations by investing in Sectra’s digital mammography system, Sectra MicroDose Mammography. Curato will thus be able to offer Norwegian women the opportunity to choose mammography with the lowest dose of radiation in the market. The order comprises three mammography stands.

2 Nov 2009

Extending hepatitis C treatment for liver transplant patients results in sustained viral clearance

Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.

2 Nov 2009